Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun 1;4(11):639-644.
doi: 10.1016/j.jaccas.2022.02.016.

Multidisciplinary Approach to Hemodynamic Management During High-Risk Ventricular Tachycardia Ablation

Aditya Bharadwaj  1 , Melissa D McCabe  2 , Tahmeed Contractor  1 , Hyungjin Ben Kim  1 , Antoine Sakr  1 , Anthony Hilliard  1 , Ravi Mandapati  1 , Rahul Bhardwaj  1
Affiliations
Case Reports

Multidisciplinary Approach to Hemodynamic Management During High-Risk Ventricular Tachycardia Ablation

Aditya Bharadwaj et al. JACC Case Rep. .

Abstract

Percutaneous ventricular assist devices have been used for high-risk ventricular tachycardia ablation when hemodynamic decompensation is expected. Utilizing a case example, we present our experience with development of a coordinated, team-based approach focused on periprocedural management of patients with high-risk ventricular tachycardia. (Level of Difficulty: Advanced.).

Keywords: AHD, acute hemodynamic decompensation; CPO, cardiac power output; HR-VTA, high-risk ventricular tachycardia ablation; ICD, implantable cardioverter-defibrillator; LV, left ventricular; MCS, mechanical circulatory support; SVO2, mixed venous oxygen saturation; VT, ventricular tachycardia; VTA, ventricular tachycardia ablation; ablation; hemodynamics; multidisciplinary care; pVAD, percutaneous ventricular assist device; percutaneous mechanical circulatory support; ventricular tachycardia.

PubMed Disclaimer

Conflict of interest statement

This work was supported by research funding from Abiomed. Dr Bharadwaj is a consultant, speaker, and proctor for Abiomed. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Left Ventricular Mapping: Clinical Ventricular Tachycardia (A) Left ventricular activation map of the clinical ventricular tachycardia. (B) Left ventricular voltage map showing large anterior scar extending to the septum along with ablation lesions. (C) Left bundle morphology, superior axis, precordial transition in V5, and positive in lead I.
Figure 2
Figure 2
Left Ventricular Mapping: Nonclinical Ventricular Tachycardia (A) Two views of a left ventricular activation map of induced nonclinical ventricular tachycardia showing focal breakthrough from the anterior wall. (B) Right bundle, inferior axis, negative in lead I and negative in V2 to V6.
Figure 3
Figure 3
Objective Assessment of Tissue Perfusion Maintenance of end-organ perfusion even during induction of ventricular tachycardia is paramount. We aim to maintain cardiac index >2 L/min/m2, mixed venous oxygenation >60%, cardiac power output >0.6 W, and lactate <2 mmol/L, as well as blood pressure and cerebral oximetry 60% to 90% and within 20% of baseline.
Figure 4
Figure 4
Weaning MCS Prolonged tachycardia and hypotension may provoke myocardial ischemia and stunning, increasing reliance on mechanical circulatory support (MCS). We recommend assessment of cardiac power output (CPO), pulsatility of the arterial waveform, mixed venous oxygenation saturation (SVO2), and lactate before decreasing device flows. We suggest reassessing weaning criteria after each reduction and before withdrawing MCS.
Figure 5
Figure 5
Loss of Intrinsic Arterial Pulsatility Hemodynamics from the percutaneous ventricular assist device console showing loss of pulsatility of native heart and dependence on mechanical circulatory support.
See this image and copyright information in PMC

References

    1. Tzou W.S., Tung R., Frankel D.S., et al. Ventricular tachycardia ablation in severe heart failure: an international ventricular tachycardia ablation center collaboration analysis. Circ Arrhythm Electrophysiol. 2017;10 - PubMed
    1. Mariani S., Napp L.C., Lo Coco V., et al. Mechanical circulatory support for life-threatening arrhythmia: a systematic review. Int J Cardiol. 2020;308:42–49. - PubMed
    1. Aryana A., Gearoid O'Neill P., Gregory D., et al. Procedural and clinical outcomes after catheter ablation of unstable ventricular tachycardia supported by a percutaneous left ventricular assist device. Heart Rhythm. 2014;11:1122–1130. - PubMed
    1. Muser D., Castro S.A., Liang J.J., Santangeli P. Identifying risk and management of acute haemodynamic decompensation during catheter ablation of ventricular tachycardia. Arrhythm Electrophysiol Rev. 2018;7:282–287. - PMC - PubMed
    1. Muser D., Liang J.J., Castro S.A., et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis. Heart Rhythm. 2018;15:1500–1506. - PubMed

Publication types

LinkOut - more resources